MyFinsight
Home
Blog
About
Cash and cash
equivalents
$13,756K
(-31.24%↓ Y/Y)
Prepaid expenses
$557K
(11.40%↑ Y/Y)
Receivables
$20K
(0.00%↑ Y/Y)
Intangible assets
$27,595K
(-32.90%↓ Y/Y)
Total current assets
$14,333K
(-30.17%↓ Y/Y)
Goodwill
$8,138K
(0.00%↑ Y/Y)
Equipment, net
$7K
(-50.00%↓ Y/Y)
Total assets
$50,073K
(-28.27%↓ Y/Y)
Total liabilities and
stockholders equity
$50,073K
(-28.27%↓ Y/Y)
Total stockholders'
equity
$48,211K
(-24.14%↓ Y/Y)
Total liabilities
$1,862K
(-70.23%↓ Y/Y)
Accumulated deficit
-$244,270K
(-9.03%↓ Y/Y)
Accumulated other
comprehensive loss
-$6,038K
(0.00%↑ Y/Y)
Additional paid-in capital
$298,518K
(1.66%↑ Y/Y)
Total current
liabilities
$1,250K
(-46.00%↓ Y/Y)
Deferred tax liability
$612K
(-73.53%↓ Y/Y)
Common stock, 0.0001
par value per share...
$1K
(0.00%↑ Y/Y)
Trade and other
payables
$1,250K
(-46.00%↓ Y/Y)
Back
Back
Balance Sheet
Grace Therapeutics, Inc. (GRCE)
Grace Therapeutics, Inc. (GRCE)
source: myfinsight.com